New insights into the optimal management of COPD: extracts from CHEST 2021 annual meeting (October 17

New insights into the optimal management of COPD: extracts from CHEST 2021 annual meeting (October 17–20, 2021)

Published:2022-04-13 Issue: Volume: Page:1-9
ISSN:1747-6348
Container-title:Expert Review of Respiratory Medicine
language:en
Short-container-title:Expert Review of Respiratory Medicine

Author:

Quint Jennifer¹,Montonen Jukka²,Singh Dave³,Wachtel Herbert⁴,Attick Sharon⁵,Palli Swetha⁶,Frazer Monica⁷,Willey Vincent⁸,Giessel Glenn⁹

Affiliation:

1. National Heart and Lung Institute, Imperial College London, London, UK

2. Global Epidemiology, Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany

3. Medicines Evaluations Unit, University of Manchester, Manchester University Foundation Hospitals Trust, Manchester, UK

4. Device Development, Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany

5. Clinical Development & Operations, Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT, USA

6. Health Economics and Outcomes Research, Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT, USA

7. Health Economics and Outcomes Research, Optum, Eden Prairie, MN, USA

8. Scientific Affairs, HealthCore, Wilmington, DE, USA

9. Pulmonary Associates of Richmond, Richmond, VA, USA

Funder

Boehringer Ingelheim

Publisher

Informa UK Limited

Subject

Public Health, Environmental and Occupational Health,Pulmonary and Respiratory Medicine,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/17476348.2022.2056022

Reference36 articles.

1. World Health Organization. The top 10 causes of death 2018 [cited 2021 Jul 7]. Available from: https://www.who.int/en/news-room/fact-sheets/detail/the-top-10-causes-of-death

2. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease (2019 report) 2019. [cited 2021 Jul 7]. Available from: https://goldcopd.org/wp-content/uploads/2018/11/GOLD-2019-v1.7-FINAL-14Nov2018-WMS.pdf

3. World Health Organization. COPD management 2016 [cited 2021 Jul 7]. Available from: https://www.who.int/respiratory/copd/management/en/

4. Acute COPD Exacerbations

5. Insights about the economic impact of chronic obstructive pulmonary disease readmissions post implementation of the hospital readmission reduction program

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery, Multiparametric Optimization, and Solid-State Driven Identification of CHF-6550, a Novel Soft Dual Pharmacology Muscarinic Antagonist and β₂ Agonist (MABA) for the Inhaled Treatment of Respiratory Diseases;Journal of Medicinal Chemistry;2024-06-10

2. Rational use of inhaled corticosteroids for the treatment of COPD;npj Primary Care Respiratory Medicine;2023-07-24

3. LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations;Journal of Clinical Medicine;2022-11-08

4. Predictors of respiratory failure after thoracic surgery: a retrospective cohort study with comparison between lobar and sub-lobar resection;Journal of International Medical Research;2022-06